VSTM
Verastem·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
VSTM fundamentals
Verastem (VSTM) released its earnings on Nov 4, 2025: revenue was 11.24M (YoY 0.00%), beat estimates; EPS was -1.35 (YoY -125.00%), missed estimates.
Revenue / YoY
11.24M
0.00%
EPS / YoY
-1.35
-125.00%
Report date
Nov 4, 2025
VSTM Earnings Call Summary for Q3,2025
- Commercial Success: $11.2 million Q3 revenue, 133 prescribers, 65% top 100 org engagement.
- Clinical Momentum: Expanded RAMP-205, RAMP-301 enrollment; VS-7375 Phase I/IIa safety positive.
- Financial Health: $137.7 million cash, $29M R&D, $21M SG&A.
- Key Risks: NCCN label expansion uncertain; patient retention data maturing.
EPS
Revenue
Revenue & Expenses
VSTM has released its 2025 Q3 earnings report, with revenue of 11.24M, reflecting a YoY change of NaN%, and net profit of -98.52M, showing a YoY change of -311.06%. The Sankey diagram below clearly presents VSTM's revenue sources and cost distribution.
Key Indicators
Verastem (VSTM) key financial stats and ratios, covering profitability, financial health, and leverage.
Verastem (VSTM)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Verastem (VSTM)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Verastem (VSTM)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Verastem (VSTM) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Verastem (VSTM) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the market's earnings forecast for Verastem next quarter?What is Verastem's latest dividend and current dividend yield?What is Verastem's gross profit margin?What were the key takeaways from Verastem’s earnings call?What is the revenue and EPS growth rate for Verastem year over year?What guidance did Verastem's management provide for the next earnings period?What does Verastem do and what are its main business segments?What factors drove the changes in Verastem's revenue and profit?
